Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28198158)

Published in Int J Rheum Dis on February 15, 2017

Authors

Ryosuke Hiwa1, Koichiro Ohmura1, Shuichiro Nakabo1, Chikashi Terao2, Kosaku Murakami1, Ran Nakashima1, Yoshitaka Imura1, Naoichiro Yukawa1, Hajime Yoshifuji1, Motomu Hashimoto3, Moritoshi Furu3, Hiromu Ito3, Takao Fujii3, Tsuneyo Mimori1

Author Affiliations

1: Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
2: Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
3: Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Articles by these authors

The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia. PLoS One (2014) 0.93

Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis--a genome-wide study combined with immunological analyses. PLoS One (2011) 0.85

Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. PLoS One (2014) 0.85

Kinematic alignment produces near-normal knee motion but increases contact stress after total knee arthroplasty: A case study on a single implant design. Knee (2015) 0.84

Periodontitis and Porphyromonas gingivalis in preclinical stage of arthritis patients. PLoS One (2015) 0.83

Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study). Rheumatol Ther (2015) 0.80

Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS One (2015) 0.78

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Clin Med Insights Circ Respir Pulm Med (2016) 0.78

Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort. PLoS One (2016) 0.75

Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis. PLoS One (2016) 0.75

The association between serious infection and disease outcome in patients with rheumatoid arthritis. Clin Rheumatol (2015) 0.75

High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach. Patholog Res Int (2017) 0.75

The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies. Respir Med (2017) 0.75

Direct and indirect pathogenic roles of autoantibodies in systemic autoimmune diseases. Allergol Int (2014) 0.75

ABIN1 is a signal-induced autophagy receptor that attenuates NF-κB activation by recognizing linear ubiquitin chains. FEBS Lett (2022) 0.75

Clinical Profile and Outcome of Large-Vessel Giant Cell Arteritis in Japanese Patients: A Single-Center Retrospective Cohort Study. Mod Rheumatol (2022) 0.75

Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients. PLoS One (2017) 0.75

Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis. Eur Spine J (2017) 0.75

Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. J Gastroenterol (2017) 0.75

A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production. Arthritis Res Ther (2017) 0.75

Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients. Semin Arthritis Rheum (2019) 0.75